XML 57 R50.htm IDEA: XBRL DOCUMENT
v3.26.1

License and Collaboration Agreement - Additional Information (Details) - USD ($) |  | 1 Months Ended | 3 Months Ended |
--- | --- | --- | --- | ---
Mar. 31, 2024 | Apr. 30, 2024 | Mar. 31, 2026 | Mar. 31, 2025 | Dec. 31, 2025
License And Collaboration Agreement [Line Items] |  |  |  |  |
Research and development expense |  |  | $ 21,431,000 | $ 10,534,000 |
Prepaid and other current assets |  |  | 5,736,000 |  | $ 7,247,000
Monash License Agreement |  |  |  |  |
License And Collaboration Agreement [Line Items] |  |  |  |  |
Payment of development milestones | $ 200,000 | $ 100,000 | 0 |  |
Maximum amount of successful development milestones per licensed product |  | 1,075,000.000 |  |  |
Maximum amount of successful commercial milestones per licensed product |  | $ 7,250,000 |  |  |
Monash License Agreement | Maximum |  |  |  |  |
License And Collaboration Agreement [Line Items] |  |  |  |  |
Percentage on net sales |  | 5.00% |  |  |
Monash License Agreement | Minimum |  |  |  |  |
License And Collaboration Agreement [Line Items] |  |  |  |  |
Percentage on net sales |  | 3.00% |  |  |
Monash Collaboration Agreement and ARPA-H Award |  |  |  |  |
License And Collaboration Agreement [Line Items] |  |  |  |  |
Award agreement, maximum total funding amount |  |  | 15,200,000 |  |
Award agreement, first phase of research committed funding amount |  |  | 3,500,000 |  |
Award agreement second phase of research maximum uncommitted funding amount |  |  | $ 11,700,000 |  |
Initial term of agreement |  |  | 48 months |  |
Agreement termination notice period |  |  | 60 days |  |
Milestones payment earned |  |  | $ 0 |  |

X
- Definition Agreement termination notice period. + References No definition available. + Details
Name: | sptx_AgreementTerminationNoticePeriod
Namespace Prefix: | sptx_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Award agreement first phase of research committed funding amount. + References No definition available. + Details
Name: | sptx_AwardAgreementFirstPhaseOfResearchCommittedFundingAmount
Namespace Prefix: | sptx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Award agreement maximum funding amount. + References No definition available. + Details
Name: | sptx_AwardAgreementMaximumFundingAmount
Namespace Prefix: | sptx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Award agreement second phase of research maximum uncommitted funding amount. + References No definition available. + Details
Name: | sptx_AwardAgreementSecondPhaseOfResearchMaximumUncommittedFundingAmount
Namespace Prefix: | sptx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Initial term of agreement. + References No definition available. + Details
Name: | sptx_InitialTermOfAgreement
Namespace Prefix: | sptx_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition License and collaboration agreement. + References No definition available. + Details
Name: | sptx_LicenseAndCollaborationAgreementLineItems
Namespace Prefix: | sptx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Maximum amount of successful commercial milestones per licensed product. + References No definition available. + Details
Name: | sptx_MaximumAmountOfSuccessfulCommercialMilestonesPerLicensedProduct
Namespace Prefix: | sptx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Maximum amount of successful development milestones per licensed product. + References No definition available. + Details
Name: | sptx_MaximumAmountOfSuccessfulDevelopmentMilestonesPerLicensedProduct
Namespace Prefix: | sptx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Milestones payment earned. + References No definition available. + Details
Name: | sptx_MilestonesPaymentEarned
Namespace Prefix: | sptx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Payment of development milestones. + References No definition available. + Details
Name: | sptx_PaymentOfDevelopmentMilestones
Namespace Prefix: | sptx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Percentage on net sales. + References No definition available. + Details
Name: | sptx_PercentageOnNetSales
Namespace Prefix: | sptx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_PrepaidExpenseAndOtherAssetsCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 220 -SubTopic 40 -Name Accounting Standards Codification -Section 55 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 220 -SubTopic 40 -Name Accounting Standards Codification -Section 55 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 985 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 730 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 912 -SubTopic 730 -Name Accounting Standards Codification -Section 25 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1 + Details
Name: | us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=sptx_MonashLicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=sptx_MonashCollaborationAgreementAndAdvancedResearchProjectsAgencyForHealthAwardMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |